Related Experiment Video
Updated: Jul 15, 2025

06:34
A Single-Channel and Non-Invasive Wearable Brain-Computer Interface for Industry and Healthcare
Published on: July 7, 2023
2.4K
Implantable Intracranial Pressure Sensor with Continuous Bluetooth Transmission via Mobile Application
Yasmeen Elsawaf1, Erik Jaklitsch2, Madison Belyea2
1Department of Neurological Surgery, Oregon Health & Science University, Portland, OR 97201, USA.
Journal of Personalized Medicine
|September 28, 2023
Summary
A new implantable device monitors intracranial pressure (ICP) continuously and wirelessly. This technology aids in detecting shunt failures in hydrocephalus patients and studying neurological conditions like NPH and IIH.
Area of Science:
- Biomedical Engineering
- Neurology
- Medical Devices
Background:
- Hydrocephalus involves excessive cerebrospinal fluid (CSF) buildup, often requiring shunt systems.
- Shunt systems are prone to failure, necessitating invasive diagnostic procedures.
- Continuous, noninvasive intracranial pressure (ICP) monitoring can aid in shunt failure detection and study of conditions like NPH and IIH.
Purpose of the Study:
- To develop and evaluate an implantable, continuous, rechargeable ICP monitoring device.
- To assess the device's accuracy and ability to detect simulated shunt failures and ICP fluctuations.
- To enable wireless data transmission via Bluetooth to mobile applications for accessible ICP monitoring.
Main Methods:
- Design and prototyping of an implantable, rechargeable ICP monitoring system.
- Ex-vivo testing of the system to simulate shunt occlusions, disconnections, and valve failures.
- Validation of ICP measurements against a ±2 mmHg margin at lower ranges and ±10% at higher ranges (20-100 mmHg).
- Integration with a mobile application for real-time ICP data display and fluctuation detection.
Main Results:
- The ICP monitoring system met design requirements at lower ICP ranges (≤20 mmHg) with an error within ±2 mmHg.
- The system demonstrated a slightly higher error (±10%) at higher ICP ranges (20-100 mmHg).
- The system successfully simulated various shunt failure scenarios and physiological ICP waves (A and B waves).
- The mobile application accurately detected simulated ICP fluctuations.
Conclusions:
- The developed macro-scale prototype represents a viable ex-vivo model for an implantable, rechargeable ICP monitoring system.
- The system has the potential to measure clinically relevant ICPs and provide continuous, accessible wireless data.
- This technology could significantly aid in the diagnosis and management of shunt failure and related neurological conditions.

